Literature DB >> 10421578

The Arp2/3 complex is essential for the actin-based motility of Listeria monocytogenes.

R C May1, M E Hall, H N Higgs, T D Pollard, T Chakraborty, J Wehland, L M Machesky, A S Sechi.   

Abstract

Actin polymerisation is thought to drive the movement of eukaryotic cells and some intracellular pathogens such as Listeria monocytogenes. The Listeria surface protein ActA synergises with recruited host proteins to induce actin polymerisation, propelling the bacterium through the host cytoplasm [1]. The Arp2/3 complex is one recruited host factor [2] [3]; it is also believed to regulate actin dynamics in lamellipodia [4] [5]. The Arp2/3 complex promotes actin filament nucleation in vitro, which is further enhanced by ActA [6] [7]. The Arp2/3 complex also interacts with members of the Wiskott-Aldrich syndrome protein (WASP) [8] family - Scar1 [9] [10] and WASP itself [11]. We interfered with the targeting of the Arp2/3 complex to Listeria by using carboxy-terminal fragments of Scar1 that bind the Arp2/3 complex [11]. These fragments completely blocked actin tail formation and motility of Listeria, both in mouse brain extract and in Ptk2 cells overexpressing Scar1 constructs. In both systems, Listeria could initiate actin cloud formation, but tail formation was blocked. Full motility in vitro was restored by adding purified Arp2/3 complex. We conclude that the Arp2/3 complex is a host-cell factor essential for the actin-based motility of L. monocytogenes, suggesting that it plays a pivotal role in regulating the actin cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421578     DOI: 10.1016/s0960-9822(99)80337-6

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  38 in total

Review 1.  Actin-based motility of intracellular microbial pathogens.

Authors:  M B Goldberg
Journal:  Microbiol Mol Biol Rev       Date:  2001-12       Impact factor: 11.056

2.  Cryptosporidium parvum infection requires host cell actin polymerization.

Authors:  D A Elliott; D J Coleman; M A Lane; R C May; L M Machesky; D P Clark
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 3.  Actin and pollen tube growth.

Authors:  L Vidali; P K Hepler
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

4.  Biophysical parameters influence actin-based movement, trajectory, and initiation in a cell-free system.

Authors:  Lisa A Cameron; Jennifer R Robbins; Matthew J Footer; Julie A Theriot
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

5.  Optimal orientation in branched cytoskeletal networks.

Authors:  D A Quint; J M Schwarz
Journal:  J Math Biol       Date:  2010-12-08       Impact factor: 2.259

6.  Arp2/3 complex-deficient mouse fibroblasts are viable and have normal leading-edge actin structure and function.

Authors:  Alessia Di Nardo; Gregor Cicchetti; Hervé Falet; John H Hartwig; Thomas P Stossel; David J Kwiatkowski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-27       Impact factor: 11.205

7.  Large-scale quantitative analysis of sources of variation in the actin polymerization-based movement of Listeria monocytogenes.

Authors:  Frederick S Soo; Julie A Theriot
Journal:  Biophys J       Date:  2005-05-06       Impact factor: 4.033

Review 8.  Listeria pathogenesis and molecular virulence determinants.

Authors:  J A Vázquez-Boland; M Kuhn; P Berche; T Chakraborty; G Domínguez-Bernal; W Goebel; B González-Zorn; J Wehland; J Kreft
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

Review 9.  Ena/VASP: towards resolving a pointed controversy at the barbed end.

Authors:  James E Bear; Frank B Gertler
Journal:  J Cell Sci       Date:  2009-06-15       Impact factor: 5.285

10.  Disruption of the Rickettsia rickettsii Sca2 autotransporter inhibits actin-based motility.

Authors:  Betsy Kleba; Tina R Clark; Erika I Lutter; Damon W Ellison; Ted Hackstadt
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.